LASSO regression and WGCNA-based telomerase-associated lncRNA signaling predicts clear cell renal cell carcinoma prognosis and immunotherapy response
Figure 9. PCA profiles showed patient distribution based on (A) Genome-wide; (B) Telomerase-related genes; (C) Telomerase-related lncRNAs; and (D) Risk score. In the high- and low-risk groups, red and green dots were more strongly separated.